Hypertension: Developing Fixed-Dose Combination Drugs for Treatment
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 7, 2018
May 8, 2019
1a5d992e-fb16-402a-8d7a-11d62e5e766f
Related Documents
Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry
Guidance DocumentSeptember 6, 2018Center for Drug Evaluation and Research
Nonallergic Rhinitis: Developing Drug Products for Treatment
Guidance DocumentSeptember 6, 2018Center for Drug Evaluation and Research
Migraine: Developing Drugs for Acute Treatment
Guidance DocumentFebruary 16, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.